Skip to content
Prudent Biotech
  • BLOG
    HOME
  • SYSTEMATIC
    INVESTING
  • NEWSLETTERS
    • Prudent BIOTECH
    • Prudent SMALL CAP
    • Prudent HEALTHCARE
  • MORE
    • FAQ
    • CONTACT US
  • LOGIN
    • LOGIN – BIOTECH
    • LOGIN – SMALL CAP
  • SIGN UP
    • SIGN UP – BIOTECH
    • RENEWAL – BIOTECH
is_archive

Jonathan Kitchen via Getty Images via Seeking Alpha
Biotechnology Stocks
Stock Market
October 21, 2025

Cidara Therapeutics: A Potential Blockbuster In Flu Prevention

Cidara’s CD388 is a novel flu prophylactic designed for universal prevention of seasonal and pandemic influenza through a single dose, with the potential to be the new standard of care.Phase
by admin
Prudent Biotech

© 2024. All Rights Reserved.